The Congressional Research Service, at congressional direction, does not permit direct public access to its products. Members of the public must connive or contrive to gain such access. So we do.
Some recent CRS reports that caught our eye include these (all pdf).
“Presidential Claims of Executive Privilege: History, Law, Practice and Recent Developments,” updated July 5, 2007.
“The Palestinian Territories: Background and U.S. Relations,” July 5, 2007.
“Restructuring EPA’s Libraries: Background and Issues for Congress,” updated June 15, 2007.
“U.S. Special Operations Forces (SOF): Background and Issues for Congress,” updated June 28, 2007.
“Airborne Laser (ABL): Issues for Congress,” updated July 9, 2007.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.